Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Ultromics, the UK-based developer of a system that uses artificial intelligence to analyse echocardiograms, completed a $10m financing round on Tuesday featuring medical research and care provider Mayo Clinic, Oxford Sciences Innovation (OSI) and Nina Capital. OSI supplied an undisclosed amount of seed capital for Ultromics in 2017 before returning for a $13.4m series A…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.